Next Century Growth Investors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.59M Sell
96,445
-2,023
-2% -$264K 0.7% 48
2025
Q4
$12M Buy
98,468
+44,118
+81% +$5.54M 0.83% 40
2025
Q3
$6.1M Sell
54,350
-65,406
-55% -$7.66M 0.44% 73
2025
Q2
$16M Buy
+119,756
New +$13.1M 1.24% 28
2024
Q4
Sell
-263,645
Closed -$41.4M 146
2024
Q3
$41.4M Sell
263,645
-72,752
-22% -$11.2M 3.35% 3
2024
Q2
$50.7M Sell
336,397
-135,818
-29% -$16.3M 4.21% 1
2024
Q1
$34.9M Buy
472,215
+9,500
+2% +$783K 3.03% 4
2023
Q4
$36.5M Sell
462,715
-14,767
-3% -$891K 3.55% 3
2023
Q3
$26.1M Buy
477,482
+34,540
+8% +$2.49M 2.84% 7
2023
Q2
$37.2M Sell
442,942
-35,145
-7% -$2.69M 3.58% 4
2023
Q1
$36.2M Sell
478,087
-148,543
-24% -$10.3M 3.98% 2
2022
Q4
$38.7M Sell
626,630
-177,550
-22% -$9.44M 4.64% 1
2022
Q3
$33.6M Sell
804,180
-91,782
-10% -$3.99M 4.09% 2
2022
Q2
$28.2M Buy
895,962
+552,301
+161% +$14.7M 3.68% 3
2022
Q1
$9.26M Buy
343,661
+181,842
+112% +$3.26M 0.92% 40
2021
Q4
$3.1M Sell
161,819
-2,934
-2% -$73.5K 0.28% 88
2021
Q3
$5.45M Buy
+164,753
New +$5.03M 0.47% 67
2020
Q1
Sell
-107,045
Closed -$2.03M 140
2019
Q4
$2.03M Buy
107,045
+22,253
+26% +$409K 0.26% 97
2019
Q3
$2.01M Sell
84,792
-2,891
-3% -$69.3K 0.32% 86
2019
Q2
$2.54M Buy
+87,683
New +$2.39M 0.32% 88

Other funds holding TMDX

Next Century Growth Investors's TMDX Position: Q1 2026 in Review

Next Century Growth Investors reduced its Transmedics (TMDX) stake by 2.1% in Q1 2026, selling an estimated $264K and leaving 96,445 shares worth $9.59M. The position accounts for 0.7% of the portfolio, ranked #48.

Next Century Growth Investors first reported a position in TMDX in Q2 2019 and has held it in 20 quarters since. The position peaked at $50.7M in Q2 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Next Century Growth Investors held 96,445 shares of Transmedics worth $9.59M as of Q1 2026.
  • Next Century Growth Investors sold 2,023 Transmedics shares in Q1 2026, an estimated $264K.
  • Transmedics made up 0.7% of Next Century Growth Investors's portfolio in Q1 2026, its #48 holding.
  • Next Century Growth Investors first reported a position in Transmedics in Q2 2019 and has held it in 20 quarters since.
  • Next Century Growth Investors's Transmedics position peaked at $50.7M in Q2 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Next Century Growth Investors's 13F filing for Q1 2026, filed 14 May 2026.